Amyloid-β (Aβ)-stimulated microglial inflammatory responses engage mitogen-activated protein kinase (MAPK) pathways in Alzheimer’s disease (AD). The gene discussed is WNK2; the disease is early-onset autosomal dominant Alzheimer disease.